In patients with breast cancer, high tumor expression of HSPA4 and elevated serum levels of anti-HSPA4 IgG were found to be associated with lymph node metastasis and poor prognosis [100]. This evidence concerns the gene HSPA4 and metastatic malignant neoplasm in the lymph nodes.